Orange Book product · Brand (NDA)
FUROSEMIDE
FUROSEMIDE
At a glance
May 22, 1984
Approved
Brand (NDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 22, 1984
42 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
FUROSEMIDE
Strength
10MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
NDA 018902
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2025LASIX ONYUBrand (NDA)
NDA 217294 · SQ INNOVATION
- 2022FUROSCIXBrand (NDA)
NDA 209988 · SCPHARMACEUTICALS
- 1984FUROSEMIDEBrand (NDA)
NDA 019036 · ABRAXIS PHARM
- 1984FUROSEMIDEBrand (NDA)
NDA 018750 · EPIC PHARMA LLC
- 1983FUROSEMIDEBrand (NDA)
NDA 018579 · AM REGENT
- 1983FUROSEMIDEBrand (NDA)
NDA 018413 · CHARTWELL RX
- 1982FUROSEMIDEBrand (NDA)
NDA 018507 · ABRAXIS PHARM
- 1982FUROSEMIDEBrand (NDA)
NDA 018415 · ESJAY PHARMA
- 1982FUROSEMIDEBrand (NDA)
NDA 018670 · WYETH AYERST
- 1982FUROSEMIDEBrand (NDA)
NDA 018667 · HOSPIRA
- 1982FUROSEMIDEBrand (NDA)
NDA 018420 · WARNER CHILCOTT
- —FUROSEMIDEBrand (NDA)
NDA 018267 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
